目的观察凯西莱治疗酒精性脂肪肝的疗效。方法90例酒精性脂肪肝患者随机分为两组,治疗组用凯西莱200 mg+5%葡萄糖注射液500 ml静脉滴注,1次/d,对照组用甘利欣150 mg+5%葡萄糖注射液500 ml静脉滴注,1次/d,疗程均为4周。结果治疗组与对照组疗效间比较差异有统计学意义(P<0.01)。结论凯西莱是治疗酒精性脂肪肝的一种有效药物。 Objective To observe the curative effect of Kesilai on alcoholic fatty liver. Methods Ninety patients with alcoholic fatty liver were randomly divided into two groups. The patients in the treatment group were treated with 200 mg Cassis and 500 mg glucose injection 500 ml intravenously once a day. The control group was treated with 150 mg L-lysine and 5% glucose Injection 500 ml intravenous infusion, 1 / d, treatment were 4 weeks. Results There was significant difference between the treatment group and the control group (P <0.01). Conclusion Kesilai is an effective drug for the treatment of alcoholic fatty liver.